<DOC>
	<DOC>NCT00399451</DOC>
	<brief_summary>The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS &amp; SS,to reduce pharyngeal compliance.</brief_summary>
	<brief_title>Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)</brief_title>
	<detailed_description>Polidocanol submucous sclerosis in the part of pharynges with 1% polidocanol injection.The injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palate.The injection is multi-point,and each point injection is 0.3~0.5ml;the total quantity/each time is not more than 5ml.Every patient have to be treated about 1~2 time.</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<mesh_term>Snoring</mesh_term>
	<mesh_term>Polidocanol</mesh_term>
	<criteria>OSAS &amp; SS which palatopharyngeal collapse. obstructive sleep apnea syndrome (osas) &amp; snoring subjects (ss),which anatomic narrow result in.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Sleep Apnea,Obstructive</keyword>
	<keyword>apnea-hypopnea index (AHI)</keyword>
	<keyword>polidocanol</keyword>
	<keyword>sclerotherapy</keyword>
	<keyword>pharynges</keyword>
</DOC>